Wells Fargo maintained an Overweight rating and $29 price target on Bath & Body Works following the company’s post-Q4 earnings pullback. The firm added that the turnaround story is “right where it should be,” and thefirm recommended buying the pullback in the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Bath & Body Works price target raised to $30 from $26 at BofA
- Midday Fly By: Stocks climb as oil prices pull back
- Morning News Wrap-Up 3/4/26: Wednesday’s Biggest Stock Market Stories!
- Morning Movers: Moderna rises after entering COVID settlement agreement
- BBWI Earnings: Bath & Body Works Stock Soars on Exceedingly Strong Q4 Results
